FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal ...

The FDA has alerted healthcare providers not to use Cardinal Health (NYSE:CAH) Monoject syringes with syringe pumps and patient-controlled analgesia, or PCA, pumps until it further evaluates reports ...

The FDA has doled out its most serious classification to a recall of some Cardinal Health medical supplies. In this case, the recall doesn’t describe a product removal, but merely a correction to the ...

The Food and Drug Administration voiced concerns in a Monday letter that Cardinal Health failed to sufficiently mitigate the risk of incompatibility between its syringes and certain pumps in its ...

Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's Monoject ...

The FDA has identified this as a Class I recall, the most serious type of recall. There have been 13 reported injuries. There have been no reports of death. Get the Strategy to Trade Pre-Fed Setups ...

Cardinal Health is warning customers of more than 32 million syringes because they have different dimensions than older brands, resulting in compatibility issues with syringe pumps, the FDA said Nov.

Nov 20 (Reuters) - The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's (CAH.N), opens new tab Monoject syringes with ...

Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson (BDX.N), opens new tab is recalling its Alaris infusion pumps due to compatibility issues with ...